Associated Papers
Postazacitidine clone size predicts long-term outcome of patients with myelodysplastic syndromes and related myeloid neoplasms.
Nannya Y et al.
Blood Advances, 2023
36989067 (PubMed )
Supplement: BLOODA_ADV-2022-009564-mmc2.xlsx › SuppTable2
Distinct genomic landscape of Chinese pediatric acute myeloid leukemia impacts clinical risk classification.
Liu T et al.
Nature Communications, 2022
Ultra-Sensitive CSF3R Deep Sequencing in Patients With Severe Congenital Neutropenia.
Klimiankou M et al.
Frontiers in Immunology, 2019
Characterization of the leukemogenic potential of distal cytoplasmic CSF3R truncation and missense mutations.
Zhang H et al.
Leukemia, 2017
CSF3R mutations have a high degree of overlap with CEBPA mutations in pediatric AML.
Maxson JE et al.
Blood, 2016
Granulocyte colony-stimulating factor receptor mutations in myeloid malignancy.
Liongue C et al.
Frontiers in Oncology, 2014
Select a paper to view details